Illumina Focuses on New Sequencer, Array Products; Q4 Revenues to Beat Estimates
January 13, 2010
Illumina Focuses on New Sequencer, Array Products; Q4 Revenues to Beat Estimates
Illumina unveiled a new sequencer and said China's BGI has ordered 128 of the new instruments. Company officials also provided early Q4 revenues and touted its new BeadChip product at the JP Morgan Healthcare Conference.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Illumina CEO Discusses ENCODE, GWAS, and NIH Funding at Investor Conference
September 18, 2012 / BioArray News - Amid Declining Revenues, Illumina Plans to Restructure, Focus on Clinical Market
October 25, 2011 / In Sequence - Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 2, 2011 / In Sequence - Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
February 15, 2011 / In Sequence - Stronger-than-Expected Demand for HiSeq Contributes to 50 Percent Boost in Sequencing Sales for Illumina in Q2
August 3, 2010 / In Sequence